Developer docs
API playgroundTry for free, no card

Search company profiles

Yuri

Full company profile

uuid0006srx

Namestring
Yuri
Legal namestring
Yuri GmbH
Websiteurl
yurigravity.com
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Yuri GmbH is a German space biotech company founded in 2019 and headquartered in Meckenbeuren, with engineering operations in Luxembourg (Yuri LUX GmbH). The company develops and operates hardware platforms that enable biological and pharmaceutical research in microgravity conditions, primarily aboard the International Space Station and next-generation commercial orbital destinations. Its core product stack centers on ScienceTaxi — a space-based life-sciences incubator that can host up to 38 modular ScienceShell mini-bioreactors per launch with automated temperature control, real-time data collection, and an onboard centrifuge for adjustable gravity comparisons — complemented by ground-based simulation equipment including the Random Positioning Machine (acquired from Airbus Defence and Space Netherlands in January 2023) and the Yuri Clinostat.

The company's commercial offering combines hardware sales and rental of ground simulators with a Lab-as-a-Service model covering the full microgravity experiment lifecycle: experiment design, hardware integration, launch logistics via partnerships with SpaceX, Sierra Space, Northrop Grumman, Rocket Factory Augsburg, and others, in-orbit operations, and sample return. Yuri targets pharmaceutical and biotech firms (including GSK), research institutions and universities (MIT, Charité Berlin, Centre for Genomic Regulation), space agencies (NASA, ESA, DLR), and emerging commercial customers in food technology and synthetic biology. The company reports 151 space labs launched, 61 customers across four continents, and 138 space biology publications.

Revenue derives from three streams: managed Lab-as-a-Service contracts (including ESA's mid-seven-figure Biomission2021 award), direct hardware sales and rental of RPM and Clinostat units, and professional services for space mission integration. Yuri supplements direct enterprise sales with event-driven partnership development at venues like Weltraumkongress Berlin, and is positioning for the post-ISS era through its ESA contract for the Vast Haven-1 commercial station (2027) and a partnership with The Exploration Company for Nyx spacecraft integration. The company is privately held with no disclosed equity funding rounds in the available record.

Short descriptiontext

Yuri is a German space biotech company founded in 2019 that develops and operates microgravity research hardware — including the ScienceTaxi incubator, ScienceShell mini-bioreactors, and ground simulators — serving pharmaceutical companies, research institutions, and space agencies via a Lab-as-a-Service model.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersMeckenbeuren, Germany
HQ citystring
Meckenbeuren
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
space biotech hardware, microgravity research services, lab-as-a-service, life science incubators, ground simulation devices
Industry1 code
PRIMARYIMABACAI
Spacecraft Avionics, Flight Computers & Software
NAICS code2 codes
  • Guided Missile and Space Vehicle Manufacturing336414
  • Scientific Research and Development Services5417
SIC code2 codes
  • Guided Missiles & Space Vehicles & Parts3760
  • Services-Commercial Physical & Biological Research8731
Product category
Space Biotechnology Hardware and Microgravity Research Services
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Lab-as-a-Service
TypeManaged Services
Description

Full-service model providing end-to-end microgravity research solutions including hardware provision, mission integration, launch services, in-orbit operations, and sample return

yurigravity.com
2Hardware Sales and Rental
TypeHardware Sales
Description

Sale and rental of microgravity simulation devices including Random Positioning Machine (RPM) and Clinostat for Earth-based research

yurigravity.com
3Space Mission Services
TypeProfessional Services
Description

Transportation of experiments to ISS and other spacecraft, providing containers and integration services for researchers worldwide

yurigravity.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Yuri is a space biotech company that designs and manufactures proprietary microgravity research hardware (ScienceTaxi incubator, ScienceShell mini-bioreactors, RPM and Clinostat ground simulators) and provides end-to-end Lab-as-a-Service covering experiment design, mission integration, launch logistics, in-orbit operations, and sample return for pharmaceutical, biotech, research, and space agency customers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 151 space labs launched successfully
+3 more records
Product overview1 text field

Yuri is a space biotech company offering a modular platform-plus-services architecture centered on three core pillars: (1) ScienceTaxi — a space-based life science incubator facility that hosts up to 38 modular ScienceShell mini-bioreactor containers aboard the ISS and other orbital platforms, with adjustable gravity via a built-in centrifuge; (2) Ground simulators — the Random Positioning Machine (RPM, acquired from Airbus) and Yuri Clinostat — which simulate microgravity on Earth for experiment preparation and preliminary research; and (3) Yuri Lab-as-a-Service — a managed end-to-end offering covering experiment design, hardware integration, launch logistics, orbital operations, and sample return. The company also participates in the EVA joint service (with RFA and ATMOS Space Cargo) providing complete launch-to-return microgravity services, and is developing proprietary biotech products triggered by or manufactured in microgravity.

Product and service6 records
1ScienceTaxi
CategorySpace hardware platform
Description

Space-based life science incubator facility designed to host biological and medical experiments aboard the International Space Station and other orbital platforms. Features automated systems, controlled temperatures, real-time data collection, and a built-in centrifuge for adjustable gravity levels. Accommodates up to 38 experiment units (ScienceShells) per launch.

2ScienceTaxi BioSpin
CategorySpace hardware platform
Description

Next-generation state-of-the-art life sciences incubator developed by Yuri's Luxembourg engineering team, capable of hosting up to 38 individual experiments per launch with automated systems, controlled temperatures, real-time data collection, and a built-in centrifuge providing adjustable gravity levels for comparative studies across Earth, lunar, and Martian gravity references.

3ScienceShell
CategorySpace hardware module
Description

Automated modular mini-bioreactor containers that fit inside the ScienceTaxi platform, enabling a wide range of high-precision biological and medical experiments in microgravity including organoids, plants, and crystals.

4Random Positioning Machine (RPM)
CategoryGround simulation hardware
Description

Ground-based microgravity simulation device acquired from Airbus Defence and Space Netherlands, capable of simulating gravity levels between 10^-3 g and 0.9 g. Used for research into low or reduced gravity effects on biological organisms, preparation and post-flight analysis of ISS experiments. Includes PC and software, unique path algorithms with protection against pole bias, and integrated power and communication interfaces. Over 60 research groups use it globally, including NASA and ESA.

5Yuri Clinostat
CategoryGround simulation hardware
Description

Ground-based microgravity simulation device providing an affordable entry ticket to microgravity research on Earth, available for rent or purchase, used to simulate microgravity conditions 24/7 within a standard laboratory environment.

6Yuri Lab-as-a-Service
CategoryManaged microgravity research service
Description

Managed service model providing customers with full operational support for biotech research in microgravity, covering the entire lifecycle from experiment design and hardware preparation through launch, in-orbit operations, and re-entry, offered as a fully managed solution that lowers operational barriers and accelerates time to orbit for pharma, biotech, and research customers.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership14 partners
1Vast
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-17
Description

Contract to launch ESA life-science mission on Haven-1, world's first commercial space station launching in 2027. Yuri will deploy ScienceTaxi as Lab-as-a-Service solution for ESA on Haven-1. Positions Yuri as first European company to deliver institutional research services on a commercial orbital destination.

yurigravity.com
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-02-15
Description

Collaboration to test USIL's whole-body drug treatment for acute radiation syndrome on the ISS. USIL is developing countermeasures for radiation exposure with potential space applications for protecting astronauts and pilots.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-09-25
Description

Collaboration to advance biotechnology in space by combining Yuri's biotech platforms with TEC's Nyx spacecraft. Focus on synthetic biology and drug discovery. Building on successful Mission Possible launch in June 2025. Memorandum of Understanding signed to unlock new research opportunities.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-03-27
Description

Expanded partnership for ScienceTaxi BioSpin missions. Sierra Space provides payload integration, logistics, and operational support for ScienceTaxi throughout all mission phases - launch, in-orbit operations, and re-entry. Partnership builds on 2022 agreement to deliver ScienceTaxi to ISS.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-10-18
Description

Joint EVA project partnership for end-to-end microgravity service. RFA provides flexible and low-cost launch services via RFA ONE launch system from SaxaVord Spaceport in Scotland. RFA delivers ATMOS Space Cargo's Phoenix capsule with Yuri's ScienceTaxi to target orbit.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-10-18
Description

Joint EVA project partnership. ATMOS develops reusable Phoenix return capsules for safe return from LEO to Azores. Responsible for re-entry logistics, early retrieval, and recovery mission execution.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-03-16
Description

First partnership worldwide between a commercial space biotechnology company and a biomedical research institute. Collaboration to study impact of microgravity on human health, cells, and plant biology. Initial research explores bacteria survival in space environments and creation of 'space bacteria' strains with industrial applications.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Multiple partnerships including Biomission2021 contract for developing biological payloads for ISS. ESA Rising Star 2024 recognition. Contract for ESA life-science mission on Haven-1 in 2027.

9NASA
Strategic tierCoreTypeStrategic or Co-development Partner
Description

NASA partnerships for ISS research missions and payload integration. Multiple CRS mission collaborations including SpaceX CRS-26, CRS-27, and Northrop Grumman missions.

yurigravity.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership for NEMUCO experiment (nerve-muscle co-culture in microgravity). Ueberflieger2 student mission collaboration with DLR and Luxembourg Space Agency.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Joint Ueberflieger2 initiative for student experiments to ISS. Yuri Luxembourg subsidiary location.

12GSK
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pharmaceutical research partnerships for leveraging microgravity in drug discovery and development.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

University medicine hospital partnership for cell culture experiments on ISS including Cellbox-3 mission and similar experiments.

14MIT
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic research partnership with Professor Christopher Mason (Scientific Advisory Board member) and Weill Cornell Medicine.

yurigravity.com
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Israel-based space biotech offering end-to-end microgravity research services including proprietary mini-lab hardware. Direct competitor in pharma and academic microgravity research with similar Lab-as-a-Service GTM.

TypeRegional player
Description

European developer of the Nyx spacecraft with which Yuri has an active MoU. Functions as a complementary partner for access to orbit rather than a direct competitor, but overlaps in European space biotech ecosystem.

TypeDirect peer
Description

US-based space biotech company providing end-to-end Lab-as-a-Service for microgravity research on the ISS. Closest direct competitor to Yuri with overlapping customer segments (pharma, biotech, academic) and similar platform-plus-services business model.

TypeBroad incumbent
Description

Commercial space station developer with broader portfolio including crewed missions and in-orbit services. Larger incumbent that may bundle or compete with Yuri's Lab-as-a-Service on its own commercial station.

TypeBroad incumbent
Description

Dream Chaser developer and broad space-industry player (life sciences, propulsion, space stations). Both partner and potential competitor—Sierra's LIFE habitat and broader infrastructure overlap with Yuri's microgravity services.

TypeDirect peer
Description

University of Colorado-based payload developer and operator with decades of ISS flight heritage in biological research. Direct peer in space life sciences hardware and mission integration; long-standing NASA and pharma research customer relationships.

TypeDirect peer
Description

Operated by Space Applications Services, providing commercial access to ISS for experiments including biotech research. Direct peer in the European commercial ISS-access market alongside Yuri.

TypeEmerging player
Description

Microgravity research services company focused on biological experiments aboard ISS. Emerging player with overlapping customer base in academic and biotech research but smaller scale than Yuri.

9LambdaVision
TypeEmerging player
Description

Startup using microgravity-based protein crystallization for retinal implants. Consumer of microgravity biotech infrastructure like Yuri offers, representing an emerging application vertical within the same ecosystem.

TypeBroad incumbent
Description

Pioneer in commercial ISS utilization now part of Voyager Space's Starlab station effort. Established incumbent in commercial space services with deep flight heritage overlapping with Yuri's offerings.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors7 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Yuri

Space Biotechnology Hardware and Microgravity Research Servicesyurigravity.com

Yuri is a German space biotech company founded in 2019 that develops and operates microgravity research hardware — including the ScienceTaxi incubator, ScienceShell mini-bioreactors, and ground simulators — serving pharmaceutical companies, research institutions, and space agencies via a Lab-as-a-Service model.

What Yuri does

Yuri GmbH is a German space biotech company founded in 2019 and headquartered in Meckenbeuren, with engineering operations in Luxembourg (Yuri LUX GmbH). The company develops and operates hardware platforms that enable biological and pharmaceutical research in microgravity conditions, primarily aboard the International Space Station and next-generation commercial orbital destinations. Its core product stack centers on ScienceTaxi — a space-based life-sciences incubator that can host up to 38 modular ScienceShell mini-bioreactors per launch with automated temperature control, real-time data collection, and an onboard centrifuge for adjustable gravity comparisons — complemented by ground-based simulation equipment including the Random Positioning Machine (acquired from Airbus Defence and Space Netherlands in January 2023) and the Yuri Clinostat.

The company's commercial offering combines hardware sales and rental of ground simulators with a Lab-as-a-Service model covering the full microgravity experiment lifecycle: experiment design, hardware integration, launch logistics via partnerships with SpaceX, Sierra Space, Northrop Grumman, Rocket Factory Augsburg, and others, in-orbit operations, and sample return. Yuri targets pharmaceutical and biotech firms (including GSK), research institutions and universities (MIT, Charité Berlin, Centre for Genomic Regulation), space agencies (NASA, ESA, DLR), and emerging commercial customers in food technology and synthetic biology. The company reports 151 space labs launched, 61 customers across four continents, and 138 space biology publications.

Revenue derives from three streams: managed Lab-as-a-Service contracts (including ESA's mid-seven-figure Biomission2021 award), direct hardware sales and rental of RPM and Clinostat units, and professional services for space mission integration. Yuri supplements direct enterprise sales with event-driven partnership development at venues like Weltraumkongress Berlin, and is positioning for the post-ISS era through its ESA contract for the Vast Haven-1 commercial station (2027) and a partnership with The Exploration Company for Nyx spacecraft integration. The company is privately held with no disclosed equity funding rounds in the available record.

Yuri firmographics

Firmographics
Name
Yuri
Legal name
Yuri GmbH
Website
https://yurigravity.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
101–250 employees
Short description
Yuri is a German space biotech company founded in 2019 that develops and operates microgravity research hardware — including the ScienceTaxi incubator, ScienceShell mini-bioreactors, and ground simulators — serving pharmaceutical companies, research institutions, and space agencies via a Lab-as-a-Service model.
Ownership category
akta.pro rank

Yuri industry classification

Industry
Product category
Space Biotechnology Hardware and Microgravity Research Services
NAICS
Guided Missile and Space Vehicle Manufacturing (336414), Scientific Research and Development Services (5417)
SIC
Guided Missiles & Space Vehicles & Parts (3760), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYIMABACAI
Spacecraft Avionics, Flight Computers & Software

Keywords

  • Space biotech hardware
  • Microgravity research services
  • Lab-as-a-service
  • Life science incubators
  • Ground simulation devices

Where Yuri is headquartered

Location

Headquarters

HQ city
Meckenbeuren
HQ country
Germany
HQ region
Europe

Offices2 records

Markets served

Yuri business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales

Revenue model

  1. Lab-as-a-Service: Full-service model providing end-to-end microgravity research solutions including hardware provision, mission integration, launch services, in-orbit operations, and sample return
  2. Hardware Sales and Rental: Sale and rental of microgravity simulation devices including Random Positioning Machine (RPM) and Clinostat for Earth-based research
  3. Space Mission Services: Transportation of experiments to ISS and other spacecraft, providing containers and integration services for researchers worldwide

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Yuri product offering

Product offering

Core offering

Yuri is a space biotech company that designs and manufactures proprietary microgravity research hardware (ScienceTaxi incubator, ScienceShell mini-bioreactors, RPM and Clinostat ground simulators) and provides end-to-end Lab-as-a-Service covering experiment design, mission integration, launch logistics, in-orbit operations, and sample return for pharmaceutical, biotech, research, and space agency customers.

Product overview

Yuri is a space biotech company offering a modular platform-plus-services architecture centered on three core pillars: (1) ScienceTaxi — a space-based life science incubator facility that hosts up to 38 modular ScienceShell mini-bioreactor containers aboard the ISS and other orbital platforms, with adjustable gravity via a built-in centrifuge; (2) Ground simulators — the Random Positioning Machine (RPM, acquired from Airbus) and Yuri Clinostat — which simulate microgravity on Earth for experiment preparation and preliminary research; and (3) Yuri Lab-as-a-Service — a managed end-to-end offering covering experiment design, hardware integration, launch logistics, orbital operations, and sample return. The company also participates in the EVA joint service (with RFA and ATMOS Space Cargo) providing complete launch-to-return microgravity services, and is developing proprietary biotech products triggered by or manufactured in microgravity.

Differentiator

Problem solved

Functional benefit

Products and services

  • ScienceTaxi Space-based life science incubator facility designed to host biological and medical experiments aboard the International Space Station and other orbital platforms. Features automated systems, controlled temperatures, real-time data collection, and a built-in centrifuge for adjustable gravity levels. Accommodates up to 38 experiment units (ScienceShells) per launch.
  • ScienceTaxi BioSpin Next-generation state-of-the-art life sciences incubator developed by Yuri's Luxembourg engineering team, capable of hosting up to 38 individual experiments per launch with automated systems, controlled temperatures, real-time data collection, and a built-in centrifuge providing adjustable gravity levels for comparative studies across Earth, lunar, and Martian gravity references.
  • ScienceShell Automated modular mini-bioreactor containers that fit inside the ScienceTaxi platform, enabling a wide range of high-precision biological and medical experiments in microgravity including organoids, plants, and crystals.
  • Random Positioning Machine (RPM) Ground-based microgravity simulation device acquired from Airbus Defence and Space Netherlands, capable of simulating gravity levels between 10^-3 g and 0.9 g. Used for research into low or reduced gravity effects on biological organisms, preparation and post-flight analysis of ISS experiments. Includes PC and software, unique path algorithms with protection against pole bias, and integrated power and communication interfaces. Over 60 research groups use it globally, including NASA and ESA.
  • Yuri Clinostat Ground-based microgravity simulation device providing an affordable entry ticket to microgravity research on Earth, available for rent or purchase, used to simulate microgravity conditions 24/7 within a standard laboratory environment.
  • Yuri Lab-as-a-Service Managed service model providing customers with full operational support for biotech research in microgravity, covering the entire lifecycle from experiment design and hardware preparation through launch, in-orbit operations, and re-entry, offered as a fully managed solution that lowers operational barriers and accelerates time to orbit for pharma, biotech, and research customers.

Quantifiable outcome

  • 151 space labs launched successfully
  • +3 more outcomes

Companies that use Yuri

Customer profile

Named customers10 records

Segments4 records

Ideal customer profiles3 records

Yuri technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Yuri partnerships and signals

Strategic signal

Partnerships

14 partnerships are on record, tiered core and minor.

  • VastcoreStrategic or Co-development Partner · 17 April 2026Contract to launch ESA life-science mission on Haven-1, world's first commercial space station launching in 2027. Yuri will deploy ScienceTaxi as Lab-as-a-Service solution for ESA on Haven-1. Positions Yuri as first European company to deliver institutional research services on a commercial orbital destination.
  • USIL TherapeuticsminorStrategic or Co-development Partner · 15 February 2026Collaboration to test USIL's whole-body drug treatment for acute radiation syndrome on the ISS. USIL is developing countermeasures for radiation exposure with potential space applications for protecting astronauts and pilots.
  • The Exploration Company (TEC)coreStrategic or Co-development Partner · 25 September 2025Collaboration to advance biotechnology in space by combining Yuri's biotech platforms with TEC's Nyx spacecraft. Focus on synthetic biology and drug discovery. Building on successful Mission Possible launch in June 2025. Memorandum of Understanding signed to unlock new research opportunities.
  • Sierra SpacecoreStrategic or Co-development Partner · 27 March 2025Expanded partnership for ScienceTaxi BioSpin missions. Sierra Space provides payload integration, logistics, and operational support for ScienceTaxi throughout all mission phases - launch, in-orbit operations, and re-entry. Partnership builds on 2022 agreement to deliver ScienceTaxi to ISS.
  • Rocket Factory Augsburg (RFA)coreStrategic or Co-development Partner · 18 October 2023Joint EVA project partnership for end-to-end microgravity service. RFA provides flexible and low-cost launch services via RFA ONE launch system from SaxaVord Spaceport in Scotland. RFA delivers ATMOS Space Cargo's Phoenix capsule with Yuri's ScienceTaxi to target orbit.
  • ATMOS Space CargocoreStrategic or Co-development Partner · 18 October 2023Joint EVA project partnership. ATMOS develops reusable Phoenix return capsules for safe return from LEO to Azores. Responsible for re-entry logistics, early retrieval, and recovery mission execution.
  • Centre for Genomic Regulation (CRG)coreStrategic or Co-development Partner · 16 March 2023First partnership worldwide between a commercial space biotechnology company and a biomedical research institute. Collaboration to study impact of microgravity on human health, cells, and plant biology. Initial research explores bacteria survival in space environments and creation of 'space bacteria' strains with industrial applications.
  • ESAcoreStrategic or Co-development PartnerMultiple partnerships including Biomission2021 contract for developing biological payloads for ISS. ESA Rising Star 2024 recognition. Contract for ESA life-science mission on Haven-1 in 2027.
  • NASAcoreStrategic or Co-development PartnerNASA partnerships for ISS research missions and payload integration. Multiple CRS mission collaborations including SpaceX CRS-26, CRS-27, and Northrop Grumman missions.
  • DLR (German Aerospace Center)coreStrategic or Co-development PartnerPartnership for NEMUCO experiment (nerve-muscle co-culture in microgravity). Ueberflieger2 student mission collaboration with DLR and Luxembourg Space Agency.
  • Luxembourg Space AgencycoreStrategic or Co-development PartnerJoint Ueberflieger2 initiative for student experiments to ISS. Yuri Luxembourg subsidiary location.
  • GSKcoreStrategic or Co-development PartnerPharmaceutical research partnerships for leveraging microgravity in drug discovery and development.
  • Charité BerlincoreStrategic or Co-development PartnerUniversity medicine hospital partnership for cell culture experiments on ISS including Cellbox-3 mission and similar experiments.
  • MITcoreStrategic or Co-development PartnerAcademic research partnership with Professor Christopher Mason (Scientific Advisory Board member) and Weill Cornell Medicine.

Scale indicators6 records

Recent moves8 records

Expansion highlights6 records

Yuri competitors and assessment

Company assessment

Direct peers

  • SpacePharma: Israel-based space biotech offering end-to-end microgravity research services including proprietary mini-lab hardware. Direct competitor in pharma and academic microgravity research with similar Lab-as-a-Service GTM.
  • Space Tango: US-based space biotech company providing end-to-end Lab-as-a-Service for microgravity research on the ISS. Closest direct competitor to Yuri with overlapping customer segments (pharma, biotech, academic) and similar platform-plus-services business model.
  • BioServe Space Technologies: University of Colorado-based payload developer and operator with decades of ISS flight heritage in biological research. Direct peer in space life sciences hardware and mission integration; long-standing NASA and pharma research customer relationships.
  • ICE Cubes Service: Operated by Space Applications Services, providing commercial access to ISS for experiments including biotech research. Direct peer in the European commercial ISS-access market alongside Yuri.

Regional players

  • The Exploration Company: European developer of the Nyx spacecraft with which Yuri has an active MoU. Functions as a complementary partner for access to orbit rather than a direct competitor, but overlaps in European space biotech ecosystem.

Broad incumbents

  • Axiom Space: Commercial space station developer with broader portfolio including crewed missions and in-orbit services. Larger incumbent that may bundle or compete with Yuri's Lab-as-a-Service on its own commercial station.
  • Sierra Space: Dream Chaser developer and broad space-industry player (life sciences, propulsion, space stations). Both partner and potential competitor—Sierra's LIFE habitat and broader infrastructure overlap with Yuri's microgravity services.
  • NanoRacks (Voyager Space): Pioneer in commercial ISS utilization now part of Voyager Space's Starlab station effort. Established incumbent in commercial space services with deep flight heritage overlapping with Yuri's offerings.

Emerging players

  • Rhodium Scientific: Microgravity research services company focused on biological experiments aboard ISS. Emerging player with overlapping customer base in academic and biotech research but smaller scale than Yuri.
  • LambdaVision: Startup using microgravity-based protein crystallization for retinal implants. Consumer of microgravity biotech infrastructure like Yuri offers, representing an emerging application vertical within the same ecosystem.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Yuri social profiles

Digital presence

Yuri financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Yuri leadership team

Management profile

Number of profiles

Profiles6 records

Yuri subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Yuri funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Yuri M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Yuri

What does Yuri do?

Yuri is a space biotech company that designs and manufactures proprietary microgravity research hardware (ScienceTaxi incubator, ScienceShell mini-bioreactors, RPM and Clinostat ground simulators) and provides end-to-end Lab-as-a-Service covering experiment design, mission integration, launch logistics, in-orbit operations, and sample return for pharmaceutical, biotech, research, and space agency customers.

Is Yuri a public or private company?

Yuri is a private company. It is classified as venture growth investor backed and is currently operating.

When was Yuri founded?

Yuri was founded in 2019. It employs 101 to 250 people.

Where is Yuri based?

Yuri is headquartered in Meckenbeuren, Germany, in the Europe region.

How does Yuri make money?

Three revenue lines are on record. Lab-as-a-Service is the primary driver. The others are hardware Sales and Rental and space Mission Services.

Who are Yuri's main competitors?

Direct peers on record are SpacePharma, Space Tango, BioServe Space Technologies and ICE Cubes Service. The Exploration Company is listed as a regional player. Broad incumbents are Axiom Space, Sierra Space and NanoRacks (Voyager Space). Emerging players are Rhodium Scientific and LambdaVision.

Does Yuri have an API?

No public API is recorded for Yuri.

What industry is Yuri in?

Yuri's product category is Space Biotechnology Hardware and Microgravity Research Services. Its primary akta.pro industry code is IMABACAI, Spacecraft Avionics, Flight Computers & Software. Its NAICS code is 336414 and its SIC code is 3760.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
SiliconluxembourgWhat If Radiation Exposure Was No Longer A Death Sentence?USIL Therapeutics, a Luxembourg-based medical countermeasures firm founded in 2025, is developing a first-of-its-kind whole-body drug treatment for acute radiation syndrome, a condition currently classified as an official emergency gap by EU and US drug administrations with no effective treatment beyond symptomatic care. The company has completed phase one pre-clinical trials, received FDA review confirming safety for human administration, and aims to submit validation data by end of 2027 and enter the market in 2029 targeting defence ministries, first responders, and civil protection agencies in Europe, Ukraine, and Japan. USIL is also collaborating with the European Space Agency, Luxembourg company Yuri, and SpaceX to test the compound on the International Space Station for potential space applications protecting astronauts and pilots.GlobeNewswireIn-Space Manufacturing, Servicing, and Transportation Global Market Trends, Opportunities, Competitive Landscape, and Opportunities, 2020-2025, 2025-2030F, 2035FResearch and Markets has released a market report on the in-space manufacturing, servicing, and transportation sector, projecting growth from $2.18 billion in 2025 to $5.23 billion by 2030 with a compound annual growth rate of 19.1%. In October 2023, Rocket Factory Augsburg, Yuri, and ATMOS Space Cargo jointly launched Eva, an all-encompassing microgravity service for biotech research and product development, while Voyager Space acquired ZIN Technologies Inc. in March 2023 to support its Starlab initiative. The report identifies North America as currently leading the market with Asia-Pacific anticipated as the fastest-growing region, while noting that global trade changes and aerospace tariffs are driving supply chain localization efforts.SatnewsGrowing the Future: Aussie tech takes plant monitoring to space – SatNewsUniSQ's plant monitoring technology will be flown to space in an iLAuNCH Trailblazer project with Axiom Space and Yuri Gravity. The project demonstrates machine vision for early plant health detection in microgravity, with commercial applications for terrestrial controlled environment agriculture. It builds on prior Australian Space Agency-funded research.VerveyuriYuri, a German company founded in 2019, develops automated micro-labs to facilitate life sciences and drug discovery research in microgravity environments. The company has successfully launched 11 payloads to the International Space Station (ISS) and other spacecraft platforms since its inception.Verveyuri "Why space biology is a new gold rush"Startup yuri is democratizing space biology research by providing modular, reusable hardware and end-to-end services that significantly reduce the time and cost of conducting experiments in microgravity. The company currently collaborates with major pharmaceutical firms such as Eli Lilly, Sanofi Pasteur, AstraZeneca, and Colgate-Palmolive on the International Space Station and plans to launch its own liver spheroid experiment in August 2022.SelvedgeventureAstrobiology & Microgravity – Selvedge VentureYuri is an end-to-end service provider enabling research and commercial applications in microgravity for industries such as pharma, biotech, and electronics. The company offers mission definition, hardware development, and launch services using flight-proven experiment containers that interface with compatible facilities. Founded by space engineers with extensive experience from ISS missions and Mars rovers, Yuri leases hardware for both flight and ground testing.